ACTION Ontario encourages provincial narcotics strategy announcement ACTION Ontario

ACTION Ontario encourages provincial narcotics strategy announcement ACTION Ontario, a nonprofit group advocating with respect to chronic pain sufferers, welcomes the announcement of a provincial narcotics strategy and encourages the federal government to do something on the underlying problem of chronic discomfort. The government’s strategy is a good first step in tackling the narcotics concern, but we also need to address the underlying problem of how we treat chronic discomfort in this province, stated Dr. Angela Mailis-Gagnon, the chair of ACTION Ontario and founder and director of the Comprehensive Pain System at the Toronto Western Medical center .

ACT previously obtained worldwide exclusive licenses from the Brown Cancer Center for both of these cancer metabolic applications summarized below: Related StoriesCrucial modification in single DNA base predisposes children to intense form of cancerFDA grants accelerated acceptance for Tagrisso to take care of patients with advanced NSCLCNew antenna-like device makes breasts cancer surgery less difficult for surgeonsPFKFB3: Great glucose consumption is often observed in cancers cells. As PFKFB3 is the enzyme in an irreversible step of glycolysis, ACT synthesized over 100 rationally designed inhibitors of this protein.